Rudolph J R
Technology Law Group, Gowling, Strathy & Henderson, Suite 1020, 50 Queern Street North, Kitchener, Ontario, Canada N2H 6M2.
Biotechnol Adv. 1996;14(1):17-34. doi: 10.1016/0734-9750(96)00001-8.
Biotechnology is a rapidly advancing field of technology which offers many benefits to society. It is perceived that an important part of maintaining the momentum, and stimulating further advances, is to protect inventions in biotechnology, where appropriate, with a patent. Here, from the perspective of invention in biotechnology, we examine in brief, the critical elements of proper subject-matter, novelty, utility, non-obviousness and sufficiency of disclosure, as requirements of patentable invention for both the United States and Canada. Topical issues which have arisen in respect of these elements are also canvassed briefly. As will be seen, Canadian Patent Law, while still unresolved with respect to the patenting of higher life forms, is in other respects in step with the pro-patent model of the United States.